Background -Colorectal cancer (CRC) is one of the leading causes of cancer worldwide. Early diagnostic methods using serum biomarkers are required. The study of omics, most recently lipidomics, has the purpose of analyzing lipids for a better understanding of human lipidoma. The evolution of mass spectrometry methods, such as MALDI-MS technology, has enabled the detection and identification of a wide variety of lipids with great potential to open new avenues for predictive and preventive medicine. Objective -To determine the lipid profile of patients with colorectal cancer and polyps. Methods -Patients with stage I-III CRC, adenomatous polyps and individuals with normal colonoscopy were selected. All patients underwent peripheral blood collection for lipid extraction. The samples were analyzed by MALDI-MS technique for lipid identification. Statistical analysis -Univariate and multivariate (principal component analysis [PCA] and discriminant analysis by partial least squares [PLS-DA]) analyses workflows were applied to the dataset, using MetaboAnalyst 3.0 software. The ions were identified according to the class of lipids using the online database Lipid Maps (http://www.lipidmaps.org). Results -We included 88 individuals, 40 with CRC, 12 with polyps and 32 controls. Boxplot analysis showed eight VIP ions in the three groups. Differences were observed between the cancer and control groups, as well as between cancer and polyp, but not between polyps and control. The polyketide (810.1) was the lipid represented in cancer and overrepresented in polyp and control. Among the patients with CRC we observed differences between lipids with lymph node invasion (N1-2) compared to those without lymph node invasion (N). Conclusion -Possible lipid biomarkers were identified among cancer patients compared to control and polyp groups. The polyketide lipid (810.1) was the best biomarker to differentiate the cancer group from control and polyp. We found no difference between the biomarkers in the polyp group in relation to the control. HEADINGS -Colorectal neoplasms. Biomarkers. Mass spectrometry. Lipid metabolism.
INTRODUCTION
Colorectal cancer (CRC) is worldwide, the third cause of cancer and the second cause of death. An estimated 1.8 million new cases and 881,000 deaths occurred by this cancer yearly (1) . According to the Brazilian statistics, CRC is the second cause of cancer for women and the second for men (2) . CRC screening is necessary to detect polyps and cancer precociously (3) . The diagnosis at initial stages is crucial for acquiring the best prognosis. Colonoscopy, sigmoidoscopy and the fecal occult blood test (FOBT) are the main methods for CRC screening. Colonoscopy is a highly sensitive exam for identifying adenomas and cancers but is an invasive and expensive method with low adhesion even in developed countries (4) . The FOBT has low sensitivity and specificity, particularly for adenomas, but is a non-invasive and low-cost exam that reduces CRC mortality up to 16%. Sigmoidoscopy, allow partial visualization of the colon but also reduced mortality up to 30% (5) .
There is an urgent need to develop simple tests, less invasive, with high sensitivity and specificity. In recent decades, many studies have been conducted to detect molecular markers in blood, stools and urine. Mutations or methylations alterations on DNA may be interesting ways for CRC diagnosis (6) .
The MALDI-TOF MS technique is a high sensitivity and specificity analytical test for the diagnosis of cancer, applied to identify a multitude of cancer types such as gastrointestinal, lung, renal, bladder, ovarian, leukemia, melanoma and breast carcinoma. The analysis of lipid profiles can significantly contribute to the indication of some pathologies such as cancer (7) . Qualitative and quantitative assessment of lipids in blood and other body fluids may reveal new biomarkers for early diagnosis of cancer, as well as to follow cancer patients after treatment (8) .
The family of lipid is composed of a wide variety of molecular species, divided into eight classes that include 1,680,000 species complex lipids. These are involved in various physiological processes regulated by thousands of metabolic pathways. Changes in expression levels of individual lipid species may be associated with numerous diseases including cancer (9) .
There are two strategies for lipid analysis. The first one that focus on known lipids and the other one that analysis non-target lipid that provides a vast amount of data, which require the assistance of bioinformatics for data processing. This process includes three phases: the first refers to the principal component analysis (PCA) and discriminatory analysis of partial least squares (PLS-DA) that aims to identify the differential lipids. The second strategy has the purpose of recovery of the database coupled with MS/MS spectra for identification of different lipids. The third and final phase targeted the interpretation of the data for the acquisition of meaningful information (10) .
The mass spectrometry (MS) is a single analytical method that allows the identification of a wide range of molecules along the surface of a biological sample. With the advances in MS technologies, many analytical equipment was developed allowing different ionization and fragmentation approaches. The MALDI technique is the most currently used as a high-performance tool, due to its high sensitivity. MALDI-TOF/MS has become a promising tool between the present analytical platforms for lipidomic research, proving to be an attractive platform for application in lipidomics for pre-clinical biomarker studies (11, 12) .
The objective of the study was to compare the plasmatic lipid profiles of patients with colorectal cancer to controls and patients with polyps.
METHODS
Patients were selected sequentially from the Clinical Oncology, Surgical Gastroenterology and Endoscopy Division of the Federal University of Sao Paulo. The study enrolled patients with colorectal cancer or polyps and patients with normal colonoscopy of both genders, aged between 20 and 80 years.
Colon cancer patients before surgical resection of the tumor and rectal cancer patients before neoadjuvant treatment were included and compose the cancer group. Patients undergoing colonoscopy with normal colonoscopy or with adenomas polyps were included before polypectomy and compose the control and the polyps' group respectively. Patients with inflammatory bowel disease, familial adenomatous polyposis or previous history of cancer were excluded.
The study was approved by the Ethics and Clinical Research Committee Coordenadoria de Ensino e Pesquisa do Hospital São Paulo -HU/UNIFESP under no. 72523. All the patients were informed about the study and signed an Informed Consent term prior to their inclusion.
All patients underwent collection of 10 mL of peripheral blood in tubes with EDTA. After centrifugation, the plasma was stored at -80°C for further lipids analysis.
Lipid extraction
Aliquots were thawed at room temperature for lipids extraction following the protocol described by Bligh-Dyer (1959) (13) . In a tube 300 μL of the sample were added to 375 μL of chloroform and 750 μL of methanol. After homogenization, 187.5 μL of chloroform and 150 μL of distilled water were added to supernatant and centrifuged at 3000 x g for 1 minute. Approximately 200 μL of the organic phase containing the lipids were gently transferred to a new tube, which remained open at room temperature for solvent evaporation.
Samples were resuspended in 8 μL methanol, placed in duplicate spot of 1 μL by the MTP adapter 384 (Bruker Daltonics, Bremen, Germany) and coated with 1 μL of 2,5-dihydroxybenzoic acid (DHB) and alfacyano-4-hydroxycinnamic (CHCA) both in the concentration of 7 mg/mL trifluoroacetic acid (TFA) 0.01% dissolved in 70% methanol and 30% water. The acquisition of the spectra was performed in the AUTOFLEX Speedy TOF/TOF (Bruker Daltonics, Bremen, Germany) in positive mode at a range of 700-1200 m/z with the frequency 500 water 1000 shots/sec and power 90%.
Statistical analysis
A list of ions and their intensities had been generated by Flexanalysis software (Bruker Daltonics, Bremen, Germany) and afterwards exported to an Excell spreadsheet. The statistical processing was performed in MetaboAnalyst software 2.0 (http:// www.metaboanalyst.ca). The principal component analysis (PCA) and discriminant analysis by least squares (PLS-DA) were applied to evaluate the quality of the models. To find different changes on circulating lipids between the groups, 15 VIP lipids (variable importance in discriminant analysis) was obtained.
The ROC curves were generated, the area under the curve was generated to evaluate the cutoff, sensitivity, specificity for each VIP lipid in the groups.
The ions were identified by lipid subclasses by Simlipid 4 software (Premier Biosoft, Califonia, USA) and online database Lipid Maps (National Institute of Medical Sciences of the United States) (http://www.lipidmaps.org). They were identified and accepted hydrogen adducts (M+), sodium (Na+) and potassium (K+), since they form part of the composition of solvents.
RESULTS
Eighty-eight patients were included, 40 of them with CRC, 12 with adenomatous polyps and 32 controls (TABLE 1). The mean age of patients with CRC was 64 years (±15.18), with polyps was 66 years (±12.37) and for controls 58 years (±12.30). The analysis of boxplot evidenced the distribution of eight VIP ions in the three groups (TABLE 2) . All these ions were in different concentrations in CRC compared to controls or polyps. However, there was no difference between polyps and controls. (FIGURE 1 ). Due to the lack of difference between polyps and controls, all analyzes were performed between the cancer and control groups.
The cluster confirms the difference between the groups (FIGURE 2). FIGURE 1 . Boxblot of the eight ions that differentiated the groups studied, cancer-pre (red), control (green), polyp (blue).
FIGURE 2.
Lipid spectra heat map comparing the cancer group to control/polyp. The heat map confirms the difference between the cancer and control group.
Initially, 15 ions (m/z) highlighted by PLS-DA were obtained as important lipids to differentiate CRC patients from the others. The concentration between cancers patients were at least 2-fold higher. Most ions were hypo-represented in cancer patients compared to controls and polyps (FIGURE 3A and 3B).
DISCUSSION
Lipids play many essential roles in cellular functions, such as survival, proliferation and death. They are involved in the storage of chemical energy, cell signaling, cell membranes and cell-cell interactions in tissues. These cellular processes are strongly related to pathways of carcinogenesis, particularly transformation, progression and metastasis (14) .
In our study, we investigated the plasma lipid profile of patients with CRC without metastases and compared to controls and patients with polyps. The analysis tool was composed by an analytical method of MALDI-TOF mass spectrometry to identify possible lipid biomarkers for diagnosis.
Statistical data processing proceeded using the analysis of the main components PCA and the values of the variable importance in the projection (VIP) of the PLS-DA. The PCA is an unsupervised method; each of the main components detects the directions of greater variance in the data matrix, while the PLS-DA is a predictive supervised method of statistical validation for biomarkers (15) .
We observed a different mass spectrum in CRC patients. The small size of the polyps, the low degree of atypia and the reduced number of patients may be the cause of the lack of lipid difference between this group and controls.
We identified eight lipids that best represent the cancer group compared to the control group. The analysis of the ROC curve made with these lipids showed a high accuracy, sensitivity and specificity, suggesting that they may be potential biomarkers. As a way of improving these results, we propose a multiple logistic regression model composed with the eight selected metabolites and obtained the following predictive model.
Our results identified that the ions 810,16354, 782,08362; 754,04717; 727.00808; 755,05318; 761.07383; 762.67565 were hyporepresented and the ion 812,75576 m/z, hyper-represented in the cancer group, indicating the possible association of the lipids with the carcinogenic and metabolic pathways involved in carcinogenensis.
When assessing lymph node involvement, the boxplot test showed that patients with stage III tumors had difference on lipid profiles compared to the others (AUC: 0.924, CI 95%: 0.815-0.982), indicating a high sensitivity and specificity. These results suggest that the ions 71,587,337 and 76,308,826 may be potential prognostic biomarkers. 
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The ratio between the lipids that best differentiate the groups was 71,587,337 / 76,308,826 with sensitivity of 100% and specificity of 78.6%. The concentration of lipids of patients with tumors that had positive lymph node invasion (N1 or N2) was different from the patients with negative lymph node invasion (FIGURE 4). The increase of lipogenic expression in cancer cells is a common event for the development of cancer, due to rapid cell proliferation and reprogramming of energy metabolism, causing a decrease in plasma lipid levels. According to Corominas-Faja et al., the lipogenic phenotype plays a fundamental role in cellular processes, associated with transformations of cancer cells, including signal transduction, gene expression and response to therapy (16) .
The lipids were identified according to their categories and classes in polyketide (PK), fatty acids (FA) and glycerolphosphophosphates (GP). The ion 812,5576, hyper-represented in the cancer group, belongs to the category of FA, subclass N-acylentolamine (17) . These authors investigated the plasma lipid profile in patients with advanced CRC by MALDI-TOF. They also identified that GP and PK, were hypo represented in the cancer group and hyper represented in the control.
Glycerophospholipids, characterized as phospholipids, are integrators of cell membranes and play the role in cell metabolism and signaling. Demonstrating a relationship of these lipids with metabolic dysregulation and differentiation, certain lipid species strongly linked to cell signaling.
The phospholipid molecules are abundant in the plasma and heterogeneous, this fact is attributed, largely of variations of the FA, as well as the structural differences presented by them. Its structural diversity suggests critical involvement in many physiological and pathological processes (18) . Prospective studies associated high circulating choline concentration with an increased risk of CRC. Phosphatidylcholines and phosphatidylethanolamines are key components of cell membranes responsible for maintaining structural integrity (19) .
Several prospective studies suggest an association between high intake of flavonoids, particularly flavonols, anthocyanins and a decrease risk of CRC through various anti-inflammatory mechanisms, anti-oxidant properties, induction of apoptosis, inhibition of proliferation and angiogenesis (20) . Protective activities have been widely attributed to anthocyanins by negative regulation of inflammatory signaling pathways, including the light chain of NF-kB, mitogen-activated protein kinase (MAPK), c-Jun N -terminal kinase (JNK), and transducer and transcription activator (STAT). They inhibit cell proliferative pathways, such as the Wnt signaling pathway, which is upregulated in most sporadic CRC. However, the mechanisms that can suppress the colon carcinogenesis has not yet been fully elucidated (21) .
FAs have a structural role in cell membranes, influencing their fluidity, functions and cell membrane composition, as well as being the main structural component of each lipid group. Lipid metabolism is associated with carcinogenicity, progression and alterations in the expression of FA. The lipogenesis process is a known feature that may be present in malignant cells. A key enzyme, fatty acid synthase (FASN) that regulates the biosynthesis of lipogenesis de novo in many cancers, including CRC, is associated with disease aggressiveness and a poor prognosis. Suggesting that this enzyme may be a potential biomarker to investigate the relationships between lipid metabolism and cancer (22, 23) .
Fernandes Messias MC et al., 2018 described reduced levels of different forms of lysophospholipideocolin (LPC), a category of glycerolphospholipid (GP) in plasma of CRC patients. Phospholipids (PLs) play important cellular functions, such as signal transduction, post-translational modifications, homeostasis, adhesion, migration, apoptosis and neurotransmission (24) . In the presence of cancer these molecules are often subject to modifications, with marked changes in the metabolism of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) due to changes in the activity of degradative enzymes, which may be useful for the diagnosis and treatment of cancer (25) .
Yu Z et al., 2018 evaluated the lipid profiles of 199 patients with lung cancer (NSCLC) and 147 controls by MALDI. The authors defined a panel of four lipid markers with sensitivity of 81.9% and specificity of 70%; that can be lipid biomarkers for the diagnosis of lung carcinomas (26) .
The role of lipid synthesis in cancer metabolism and tumor development as well as in precancerous lesions still requires many studies to elucidate the numerous mechanisms and pathways of its development. IN clinical practice, the lipid profile is measured based on the serum concentrations of total cholesterol, highdensity lipoprotein, low-density lipoprotein and triacylglycerols being poor information for the analysis of the lipid fractions. The mass spectrometry (lipid) technique allowed identifying the specific categories of lipids. Cancer cells are characterized by changes in lipid metabolism. Membrane alterations, rupture of energetic homeostasis, cell signaling, gene expression and protein distribution, affecting several cellular functions, such as apoptosis, autophagy, necrosis, proliferation, differentiation, growth, drug resistance (27) .
In conclusion, we found different lipid profiles between the non-metastatic cancer group and the control group. Eight VIP potential lipid biomarkers were identified.
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